Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07647276 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Connective Tissue Massage and Music-Based Progressive Muscle Relaxation in Primary Dysmenorrhea

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened
    • Study completion moved earlier from Dec 30, 2026 to Nov 15, 2026
    • Primary completion date: Nov 15, 2026 to Oct 30, 2026
    • Start date changed from estimate of Jun 30, 2026 to Jun 22, 2026
    v3
  2. Primary endpoint(s) modifiedv2 Show 6 more changesShow less
    • Primary completion moved earlier from Mar 2027 to Nov 15, 2026
    • Study completion moved earlier from Jun 2028 to Dec 30, 2026
    • Start date: Jun 15, 2026 to Jun 30, 2026
    • Interventions: Connective Tissue Massage (Other), Music-based Progressive Muscle Relaxation Training (Other) to Connective Tissue Massage (Other), Music-based Progressive Muscle Relaxation (Other)
    • Secondary endpoints expanded, about 18 words
    • Study title expanded, about 2 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized controlled clinical trial aims to investigate the effects of Connective Tissue Massage (CTM) and music-based Progressive Muscle Relaxation Training (PMRT) on pain intensity, pressure pain threshold, analgesic use, and menstruation-related symptoms in women with primary dysmenorrhea. Participants will be randomly assigned to one of three groups: CTM, music-based PMRT, or control. Baseline assessment will be conducted during menstrual days 1-2 of Cycle 0. The interventions will be applied during the premenstrual intervention window of Cycle 0, from the estimated ovulation day, calculated as cycle length minus 14 days, until Cycle 1 Day 1. Post-intervention assessment will be conducted during menstrual days 1-2 of Cycle 1. No intervention will be applied after the post-intervention assessment, and follow-up assessment will be conducted during menstrual days 1-2 of Cycle 2. Outcomes including pain intensity, pressure pain threshold, analgesic use, menstrual symptoms, attitudes toward menstruation, functional and emotional impact of dysmenorrhea, and pain catastrophizing will be evaluated across menstrual cycles. Participant satisfaction and adherence to the interventions will also be assessed.
Trial Details
NCT Number NCT07647276
Lead Sponsor Pamukkale University
Collaborators: The Scientific and Technological Research Council of Turkey
Conditions
(from sponsor)		 Primary Dysmenorrhea
Related terms Pain
Enrollment 36 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov